Cas 926293-30-3,4-[(R)-3-ethoxycarbonyl-2-oxo-5-phenyl-imidazolidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester

926293-30-3

Post Buying Request

Basic information

Product Name: 4-[(R)-3-ethoxycarbonyl-2-oxo-5-phenyl-imidazolidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester
Synonyms: 4-[(R)-3-ethoxycarbonyl-2-oxo-5-phenyl-imidazolidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester
CAS NO:926293-30-3
Molecular Formula:
Molecular Weight: 417.505
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[(R)-3-ethoxycarbonyl-2-oxo-5-phenyl-imidazolidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-[(R)-3-ethoxycarbonyl-2-oxo-5-phenyl-imidazolidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester(926293-30-3)
EPA Substance Registry System: 4-[(R)-3-ethoxycarbonyl-2-oxo-5-phenyl-imidazolidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester(926293-30-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 926293-30-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

926293-30-3 Suppliers

Recommended suppliers

926293-30-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 926293-30-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,2,9 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 926293-30:
(8*9)+(7*2)+(6*6)+(5*2)+(4*9)+(3*3)+(2*3)+(1*0)=183
183 % 10 = 3
So 926293-30-3 is a valid CAS Registry Number.

926293-30-3Upstream product

926293-30-3Downstream Products

926293-30-3Relevant academic research and scientific papers

CHEMOKINE RECEPTOR BINDING COMPOUNDS

-

Page/Page column 43, (2010/11/26)

The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 926293-30-3